Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|pharmaceutical industry
    síneadh údaraithe margaíochta Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    síneadh Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Erweiterung der Arzneimittelreihe | Erweiterung der Produktreihe
    de
    line extension | line-extension | extension | extension of a marketing authorisation
    en
    Definition "authorisation for a medicine [ IATE:1443220 ] for which the applicant either holds a marketing authorisation, or has submitted a marketing authorisation application, with changes:1. To the active substance(s) [ IATE:35093 ]:(i) replacement of the active substance(s) by a different salt/ester complex/derivative (with the same therapeutic moiety) where the efficacy/safety characteristics are not significantly different;(ii) replacement by a different isomer [ IATE:1684575 ], a different mixture of isomers, of a mixture by an isolated isomer (e.g. racemate [ IATE:1083643 ] by a single enantiomer [ IATE:1684578 ]) where the efficacy/safety characteristics are not significantly different;(iii) replacement of a biological substance or product of biotechnology with one of a slightly different molecular structure. Modification of the vector used to produce the antigen/source material, including a new master cell bank from a different source where the efficacy/safety characteristics are not significantly different;(iv) a new ligand [ IATE:1463918 ] or coupling mechanism for a radiopharmaceutical [ IATE:1442709 ];(v) change to the extraction solvent [ IATE:1099828 ] or the ratio of herbal drug [ IATE:2112449 ] to herbal drug preparation [ IATE:2112450 ] where the efficacy/safety characteristics are not significantly different.2. Changes to strength [ IATE:3518706 ], pharmaceutical form [" Reference COM-Term. Coord., based on:Regulation (EC) No 1084/2003 concerning the examination of variations to the terms of a marketing authorisation for medicinal products for human use and veterinary medicinal products granted by a competent authority of a Member State
    Comment "For parenteral administration, it is necessary to distinguish between intra-arterial, intravenous, intramuscular, subcutaneous and other routes. For administration to poultry, respiratory, oral and ocular (nebulisation) routes used for vaccination are considered to be equivalent routes of administration.Not to be confused with variation [ IATE:3510047 ]"
    extension | extension d'une autorisation de mise sur le marché
    fr